Regarding the association of CRP and IL-6 with the risk of LRTIs, a cohort study indicated that elevated IL-6 levels in patients with chronic obstructive pulmonary disease increased the risk of pneumonia [53]; another study showed that long-term pneumonia risk was associated with inflammatory serum markers (i.e., CRP) [54]. This evidence concerns the gene IL6 and susceptibility to pneumonia measurement.